FDA Inspection 1001709 — Women's Fertility and Health Center
The FDA completed an inspection of Women's Fertility and Health Center on February 16, 2017 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Rockville, MD (United States)